Echidna Therapeutics

Echidna therapeutics email format

Verified email-pattern data for Echidna Therapeutics is currently limited. You can still use the company insights and contact sections below.
Echidna Therapeutics is focused on glycosyltransferases as a novel targets for anticancer therapies. A new paradigm in human biology is that the proteins which do the essential work for the body are regulated by chains of sugars added to them by glycosyltransferases and in cancer excess activity drives tumour growth and metastasis. Echidna Therapeutics has established a collaboration with the University of Melbourne, and ONJCRI/La Trobe University. Our preliminary work tests the effects of the glycosyltransferase known as MGAT5 (GnTV) knockout in T cells and cancer cells to explore its potential as an anticancer target. Our results show that MGAT5 knockout enhances CD8+ T cell activity against melanoma and colorectal cancer cells and makes tumour cells more sensitive to these T cells. The goal of Echidna Therapeutics to develop drugs that target MGAT5 as novel drugs to treat cancer.
Looking for a particular Echidna Therapeutics employee's phone or email?

Echidna Therapeutics Questions

Top Echidna Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant